Eosinophilic fasciitis: Typical abnormalities, variants and differential diagnosis of fasciae abnormalities using MR imaging

Diagnostic and Interventional Imaging

Volumn 96, Issue 4, 2015, Pages 341-348

  Kirchgesner, T ^a   Dallaudiere B ^b,c   Omoumi, P ^a   Malghem, J ^a   Vande Berg, B ^a   Lecouvet, F ^a   Houssiau, F ^a   Galant, C ^a   Larbi, A ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b HÔPITAL PELLEGRIN   (France)

^c Clinique du sport de Bordeaux Merignac   (France)

Author keywords

Eosinophilic; Fascia; Fasciitis; MRI; Shulman

Indexed keywords

DIFFERENTIAL DIAGNOSIS; EOSINOPHILIC FASCIITIS; ERYSIPELAS; HUMAN; MORPHEA; MYOSITIS; NECROTIZING FASCIITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; REVIEW; SCLERODERMA; EOSINOPHILIA; FASCIITIS;

DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; FASCIITIS; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84945578385     PISSN: None     EISSN: 22115684     Source Type: Journal    
DOI: 10.1016/j.diii.2014.06.018     Document Type: Short Survey

References (33)

1. Shulman LE. Diffuse fasciitis with eosinophilia: a new syn-drome? Trans Assoc Am Physicians 1975;88:70-86.
2. Benjamin M. The fascia of the limbs and back-a review. J Anat2009;214:1-18.
3. Kumka M, Bonar J. Fascia: a morphological description and clas-sification system based on a literature review. J Can ChiroprAssoc 2012;56:179-91.
4. Malghem J, Lecouvet FE, Omoumi P, Maldague BE, Vande BergBC. Necrotizing fasciitis: contribution and limitations of diag-nostic imaging. Joint Bone Spine 2013;80:146-54.
5. Shulman LE. Diffuse fasciitis with hypergammaglobuline-mia and eosinophilia: a new syndrome? J Rheumatol1984;11:569-70.
6. Lebeaux D, Sène D. Eosinophilic fasciitis (shulman disease). Best Pract Res Clin Rheumatol 2012;26:449-58.
7. Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, MooreSB. Eosinophilic fasciitis: clinical spectrum and therapeuticresponse in 52 cases. Semin Arthritis Rheum 1988;17:221-31.
8. Bischoff L, Derk CT. Eosinophilic fasciitis: demographics, dis-ease pattern and response to treatment: report of 12 casesand review of the literature. Int J Dermatol 2008;47:29-35.
9. Antic M, Lautenschlager S, Itin PH. Eosinophilic fasciitis 30years after-what do we really know? Report of 11 patientsand review of the literature. Dermatology 2006;213:93-101.
10. Lebeaux D, Francès C, Barete S, Wechsler B, Dubourg O, RenouxJ, et al. Eosinophilic fasciitis (shulman disease): new insightsinto the therapeutic management from a series of 34 patients. Rheumatology (Oxford) 2012;51:557-61.
11. Mrabet D, Saadi F, Chelly I, Trojet S, Zaraa I, Sahli H, et al. A case of shulman disease in a patient with systemic lupuserythematosus. Lupus 2010;19:1674-5.
12. French LE, Shapiro M, Junkins-Hopkins JM, Wolfe JT, Rook AH. Eosinophilic fasciitis and eosinophilic cellulitis in a patient withabnormal circulating clonal T cells: increased production ofinterleukin 5 and inhibition by interferon alfa. J Am Acad Der-matol 2003;49:1170-4.
13. Shakoory B, Fitzgerald SM, Lee SA, Chi DS, Krishnaswamy G. The role of human mast cell-derived cytokines in eosinophilbiology. J Interferon Cytokine Res 2004;24:271-81.
14. Daniel RS, Lavery S, Maize JC, Brown AN, Bolster MB. Unilat-eral eosinophilic fasciitis: an under-recognized subtype? J ClinRheumatol 2009;15:247-9.
15. Spinner RJ, Ginsburg WW, Lie JT, Kumta SM, Leung PC. Atypicaleosinophilic fasciitis localized to the hands and feet: a reportof four cases. J Rheumatol 1992;19:1141-6.
16. Baumann F, Brühlmann P, Andreisek G, Michel BA, Marincek B, Weishaupt D. MRI for diagnosis and monitoring of patients witheosinophilic fasciitis. AJR Am J Roentgenol 2005;184:169-74.
17. Endo Y, Tamura A, Matsushima Y, Iwasaki T, Hasegawa M, NagaiY, et al. Eosinophilic fasciitis: report of two cases and a sys-tematic review of the literature dealing with clinical variablesthat predict outcome. Clin Rheumatol 2007;26:1445-51.
18. Naoui A, Bouslama K, Abdallah M, Hamzaoui S, Arbi T, Bahri F, et al. Eosinophilic fasciitis (shulman's disease): a case series of11 patients. Rev Med Interne 2010;31:535-9.
19. Desvignes-Engelbert A, Saulière N, Loeuille D, Blum A, Chary-Valckenaere I. Polymyalgia revealing eosinophilic fasciitis in ayoung male: contribution of magnetic resonance imaging. JointBone Spine 2010;77:367-8.
20. Kissin EY, Garg A, Grayson PC, Dubreuil M, Vradii D, York M, et al. Ultrasound assessment of subcutaneous compressibility:a potential adjunctive diagnostic tool in eosinophilic fasciitis. J Clin Rheumatol 2013;19:382-5.
21. Le Tallec Y, Arlet P, De La Roque PM, et al. Magnetic resonanceimaging in eosinophilic fasciitis. J Rheumatol 1991;18:636-7.
22. Al-Shaikh A, Freeman C, Avruch L, McKendry RJ. Use of mag-netic resonance imaging in diagnosing eosinophilic fasciitis. Report of two cases. Arthritis Rheum 1994;37:1602-8.
23. Moulton SJ, Kransdorf MJ, Ginsburg WW, Abril A, PersellinS. Eosinophilic fasciitis: spectrum of MRI findings. AJR Am JRoentgenol 2005;184:975-8.
24. Michet CJ, Doyle JA, Ginsburg WW. Eosinophilic fasciitis: reportof 15 cases. Mayo Clin Proc 1981;56:27-34.
25. Horger M, Fierlbeck G, Kuemmerle-Deschner J, TzaribachevN, Wehrmann M, Claussen CD, et al. MRI findings in deepand generalized morphea (localized scleroderma). AJR Am JRoentgenol 2008;190:32-9.
26. Freire V, Becce F, Feydy A, Guérini H, Campagna R, AllanoreY, et al. MDCT imaging of calcinosis in systemic sclerosis. ClinRadiol 2013;68:302-9.
27. Schulze M, Kötter I, Ernemann U, Fenchel M, TzaribatchevN, Claussen CD, et al. MRI findings in inflammatory musclediseases and their noninflammatory mimics. AJR Am JRoentgenol 2009;192:1708-16.
28. McMahon CJ, Wu JS, Eisenberg RL. Muscle edema. AJR Am JRoentgenol 2010;194:W284-92.
29. Fechner A, Hummel V, Moustarhfir M, Manelfe J, Schouman-Claeys E, Dallaudière B. Systemic lupus erythematosus withpolyarthralgias due to myelofibrosis in a 49-year-old female. Diagn Interv Imaging 2014;95:323-4.
30. Dion E, Chérin P. Use of muscular MRI in inflammatorymyopathies. Rev Med Interne 2004;25:435-41.
31. Yoshida K, Kurosaka D, Joh K, Matsushima S, Takahashi E, Hirai K, et al. Fasciitis as a common lesion of dermatomyosi-tis, demonstrated early after disease onset by en bloc biopsycombined with magnetic resonance imaging. Arthritis Rheum2010;62:3751-9.
32. Dion E, Cherin P, Payan C, Fournet JC, Papo T, Maisonobe T, et al. Magnetic resonance imaging criteria for distinguishingbetween inclusion body myositis and polymyositis. J Rheumatol2002;29:1897-906.
33. Loh NN, Ch'en IY, Cheung LP, Li KC. Deep fascial hyper-intensity in soft-tissue abnormalities as revealed by t2-weighted MR imaging. AJR Am J Roentgenol 1997;168:1301-4.